Deltec Asset Management LLC Athenex, Inc. Transaction History

Deltec Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	SELL	$0.24 - $1.11 $4,800 - $22,200	-20,000 Reduced 44.78%	24,665 $7,000
Q2 2022 Jul 18, 2022	SELL	$0.41 - $0.91 $1,230 - $2,730	-3,000 Reduced 6.29%	44,665 $18,000
Q4 2021 Jan 25, 2022	SELL	$1.36 - $2.94 $57,120 - $123,480	-42,000 Reduced 46.84%	47,665 $65,000
Q3 2021 Oct 13, 2021	SELL	$2.97 - $4.84 $1.5 Million - $2.44 Million	-505,136 Reduced 84.93%	89,665 $270,000
Q2 2021 Jul 15, 2021	SELL	$3.71 - $5.13 $222,600 - $307,800	-60,000 Reduced 9.16%	594,801 $2.75 Million
Q1 2021 Apr 21, 2021	SELL	$4.08 - $14.75 $408,000 - $1.48 Million	-100,000 Reduced 13.25%	654,801 $2.82 Million
Q4 2020 Jan 20, 2021	BUY	$11.06 - $14.01 $2.43 Million - $3.08 Million	219,730 Added 41.07%	754,801 $8.35 Million
Q3 2020 Oct 23, 2020	BUY	$10.26 - $14.55 $5.49 Million - $7.79 Million	535,071 New	535,071 $6.47 Million

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Deltec Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Deltec Asset Management LLC with notifications on news.